{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:59:52Z","timestamp":1790078392395,"version":"4.0.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/inf.0000000000000894","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T15:06:26Z","timestamp":1442329586000},"page":"1349-1354","source":"Crossref","is-referenced-by-count":20,"title":["Decreased Mitochondrial Function Among Healthy Infants Exposed to Antiretrovirals During Gestation, Delivery and the Neonatal Period"],"prefix":"10.1097","volume":"34","author":[{"given":"Antoni","family":"Noguera-Julian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Mor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00f2ria","family":"Garrabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Em\u00edlia","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Cardellach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e0udia","family":"Fortuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-15-20210202","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway.","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"R5-15-20210202","doi-asserted-by":"crossref","first-page":"23616","DOI":"10.1074\/jbc.M101114200","article-title":"Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma.","volume":"276","author":"Lim","year":"2001","journal-title":"J Biol Chem"},{"key":"R6-15-20210202","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy.","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet"},{"key":"R7-15-20210202","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.","volume":"346","author":"Cote","year":"2002","journal-title":"N Engl J Med"},{"key":"R8-15-20210202","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/INF.0b013e3182253c54","article-title":"Mitochondrial impact of human immunodeficiency virus and antiretrovirals on infected pediatric patients with or without lipodystrophy.","volume":"30","author":"Moren","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R9-15-20210202","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/jac\/dkm411","article-title":"HIV and mitochondrial toxicity in children.","volume":"61","author":"Foster","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1517\/17425255.2010.526602","article-title":"Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.","volume":"6","author":"Koczor","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R12-15-20210202","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.","volume":"354","author":"Blanche","year":"1999","journal-title":"Lancet"},{"key":"R13-15-20210202","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/00002030-200308150-00006","article-title":"French Perinatal Cohort Study Group. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort.","volume":"17","author":"Barret","year":"2003","journal-title":"AIDS"},{"key":"R14-15-20210202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e3280d5a786","article-title":"In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.","volume":"21","author":"Brogly","year":"2007","journal-title":"AIDS"},{"key":"R15-15-20210202","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1542\/peds.2004-0955","article-title":"Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.","volume":"114","author":"Noguera","year":"2004","journal-title":"Pediatrics"},{"key":"R16-15-20210202","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/01.inf.0000086400.93257.74","article-title":"Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.","volume":"22","author":"Alimenti","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R17-15-20210202","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00126334-200306010-00010","article-title":"Women and Infants Transmission Study (WITS) Group. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.","volume":"33","author":"Poirier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R18-15-20210202","doi-asserted-by":"crossref","first-page":"e1189","DOI":"10.1542\/peds.2008-2771","article-title":"Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.","volume":"124","author":"Aldrovandi","year":"2009","journal-title":"Pediatrics"},{"key":"R19-15-20210202","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1310\/hct0902-126","article-title":"AIDS Clinical Trials Group A5084. Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.","volume":"9","author":"McComsey","year":"2008","journal-title":"HIV Clin Trials"},{"key":"R20-15-20210202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/591253","article-title":"Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.","volume":"198","author":"Cote","year":"2008","journal-title":"J Infect Dis"},{"key":"R21-15-20210202","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1468-1293.2011.00945.x","article-title":"Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress.","volume":"13","author":"Ross","year":"2012","journal-title":"HIV Med"},{"key":"R22-15-20210202","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/aid.2010.0204","article-title":"Short communication: transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected children.","volume":"27","author":"Brogly","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R23-15-20210202","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/QAI.0b013e31825aa89c","article-title":"CIHR Emerging Team Grant on HIV Therapy and Aging: CARMA. Leukocyte telomere length in HIV-infected pregnant women treated with antiretroviral drugs during pregnancy and their uninfected infants.","volume":"60","author":"Imam","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-15-20210202","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e32835142eb","article-title":"CIHR Emerging Team Grant on HIV Therapy and Aging (CARMA). Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy.","volume":"26","author":"Jitratkosol","year":"2012","journal-title":"AIDS"},{"key":"R25-15-20210202","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QAD.0b013e32834f3232","article-title":"Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.","volume":"26","author":"Hernandez","year":"2012","journal-title":"AIDS"},{"key":"R26-15-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/em.20201","article-title":"Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.","volume":"48","author":"Divi","year":"2007","journal-title":"Environ Mol Mutagen"},{"key":"R27-15-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/135965350901400309","article-title":"Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy.","volume":"14","author":"Gingelmaier","year":"2009","journal-title":"Antivir Ther"},{"key":"R28-15-20210202","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00126334-200304010-00004","article-title":"Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy.","volume":"32","author":"Shiramizu","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-15-20210202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0022-1759(81)90245-3","article-title":"Three-step isolation of human blood monocytes using discontinuous density gradients of Percoll.","volume":"41","author":"Fluks","year":"1981","journal-title":"J Immunol Methods"},{"key":"R30-15-20210202","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1046-2023(02)00036-1","article-title":"In vivo and in organello assessment of OXPHOS activities.","volume":"26","author":"Barrientos","year":"2002","journal-title":"Methods"},{"key":"R32-15-20210202","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.bbrc.2003.11.177","article-title":"Guideline to reference gene selection for quantitative real-time PCR.","volume":"313","author":"Radonic","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R33-15-20210202","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0270(97)00204-5","article-title":"Cytochrome c oxidase assay in minute amounts of human skeletal muscle using single wavelength spectrophotometers.","volume":"80","author":"Miro","year":"1998","journal-title":"J Neurosci Methods"},{"key":"R34-15-20210202","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2010.08.620","article-title":"Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).","volume":"57","author":"Lipshultz","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R35-15-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/toxsci\/kfq235","article-title":"Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).","volume":"118","author":"Divi","year":"2010","journal-title":"Toxicol Sci"},{"key":"R36-15-20210202","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00002030-200404300-00009","article-title":"Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir.","volume":"18","author":"Divi","year":"2004","journal-title":"AIDS"},{"key":"R37-15-20210202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/088922204322749530","article-title":"Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine.","volume":"20","author":"Gerschenson","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R38-15-20210202","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1212\/01.WNL.0000033795.17156.00","article-title":"Diagnostic criteria for respiratory chain disorders in adults and children.","volume":"59","author":"Bernier","year":"2002","journal-title":"Neurology"},{"key":"R39-15-20210202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1517\/14740338.2011.542145","article-title":"From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir.","volume":"10","author":"Curran","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"R40-15-20210202","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/QAI.0b013e318250455e","article-title":"Mitochondrial evolution in HIV-infected children receiving first- or second-generation nucleoside analogues.","volume":"60","author":"Moren","year":"2012","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T21:45:56Z","timestamp":1653169556000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201512000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000894","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}